After obtaining her Ph.D. in molecular pathology from the University of St Andrews, Scotland, Dr. Williams spent her first post-doc in the Wolpin-Nowak laboratory at Dana-Farber Cancer Institute, Boston. Here she worked on expression subtypes in pancreatic ductal adenocarcinoma where she developed a multiplex immunofluorescence assay for the determination of expression subtypes. She next moved to the Le Quesne laboratory at the Beatson Institute for Cancer Research, Glasgow where she employed the Nanostring DSP platform for the characterization of histo-morphologies in non-small cell lung cancer. She is now a Junior Group Leader working in the group on the application of spatial-omics modalities to investigate solid tumour ecology.